Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.



Status:Active, not recruiting
Conditions:Colorectal Cancer, Gastrointestinal
Therapuetic Areas:Gastroenterology, Oncology
Healthy:No
Age Range:18 - 89
Updated:8/31/2018
Start Date:April 2013
End Date:December 2022

Use our guide to learn which trials are right for you!

The effectiveness of colonoscopy in reducing colorectal cancer mortality relies on the
detection and removal of neoplastic polyps. Because the risk of prevalent cancer and of
transition to cancer increases with polyp size, effective and safe resection of large polyps
is particularly important. Large polyps ≥20mm are removed by so-called endoscopic mucosal
resection (EMR) using electrocautery snares. Resection of these large polyps is associated
with a risk of severe complications that may require hospitalization and additional
interventions. The most common risk is delayed bleeding which is observed in approximately
2-9% of patients. A recent retrospective study suggests that closure of the large mucosal
defect after resection may decrease the risk of delayed bleeding. However, significant
uncertainty remains about the polypectomy techniques to optimizing resection and minimizing
risk. Important aspects that may affect risk include clipping of the mucosal defect and
electrocautery setting.

Aim 1. The primary aim of the study is to compare the rate of delayed bleeding complications
in patients undergoing endoscopic resection of large polyps between:

- A) Closing the mucosal defect after resection (Clip group) and

- B) Not closing the mucosal defect after resection (No clip group).

Aim 2. The secondary aim of the study is to compare the rate of overall complications in
patients undergoing endoscopic resection of large polyps between two cautery settings:

- A) Low power coagulation and

- B) Endocut.

Inclusion Criteria:

- Any patient ≥18 and ≤89 who presents for a colonoscopy and who does not have criteria
for exclusion

- Patients with a ≥20mm non-pedunculated colon polyp

Exclusion Criteria:

- Patients with known (biopsy proven) invasive carcinoma in a potential study polyp

- Pedunculated polyps (as defined by Paris Classification type Ip or Isp)

- Patients with ulcerated depressed lesions (as defined by Paris Classification type
III)

- Patients with inflammatory bowel disease

- Patients who are receiving an emergency colonoscopy

- Poor general health (ASA class>3)

- Patients with coagulopathy with an elevated INR ≥1.5, or platelets <50

- Poor bowel preparation

- Pregnancy
We found this trial at
1
site
White River Junction, Vermont 05001
Principal Investigator: Heiko Pohl, MD
Phone: 802-295-9363
?
mi
from
White River Junction, VT
Click here to add this to my saved trials